Olga Balafa1, Evangelia Dounousi2, Ioannis Giannikouris3, Ioannis Petrakis4, Anastasia Georgoulidou5, Despina Karassavidou6, Apostolos Kokalis7, Aristeidis Stauroulopoulos8, Marios Theodoridis9, Ignatios Oikonomidis10, Georgios Triantafyllis3, Ourania Tsotsorou11, Kimon Tzannis11, Dimitra Bacharaki11. 1. Nephrology Department, University Hospital of Ioannina, Ioannina, Greece. olgabalafa@gmail.com. 2. Nephrology Department, University Hospital of Ioannina, Ioannina, Greece. 3. Medifil SA Hemodialysis Center, Athens, Greece. 4. Nephrology Department, University Hospital of Heraklion, Heraklion, Greece. 5. Nephrology Department, General Hospital of Komotini, Komotini, Greece. 6. Nephrology Department, General Hospital of Prolemaida, Ptolemaida, Greece. 7. Clinitest EE Hemodialysis Center, Athens, Greece. 8. IASIO Hospital, General Clinic of Kalithea, Nephrology, Athens, Greece. 9. Nephrology Department, University Hospital of Alexandroupolis, Alexandroupolis, Greece. 10. Cardiology Department, Attikon University Hospital, Athens, Greece. 11. Nephrology Department, Attikon University Hospital, Athens, Greece.
Abstract
PURPOSE: Left ventricular hypertrophy (LVH) represents one of the main risk factors for cardiovascular mortality in dialysis patients. Low serum magnesium Mg is related with increased mortality in general and dialysis population. Aim of our study was to evaluate the association of Mg with LVH and cardiac geometry in dialysis patients. METHODS: Hemodialysis (HD) and peritoneal dialysis (PD) patients from nine nephrology departments were included. Echocardiographic LVH was defined by LV mass index > 95 g/m2 in women and > 115 g/m2 in men. Four LV geometric patterns were defined: normal, concentric remodeling, eccentric LVH and concentric LVH. Demographic and laboratory data were collected. RESULTS: 133 patients (68 HD, 65 PD) with a median age of 63 years (IQR 52-74) were studied. Mg correlated positively with creatinine, HDL and negatively with CRP levels and BMI. There were no significant differences in Mg between the modality groups. 80 patients presented LVH (43 HD and 37 PD patients). Patients with LVH were older (median age 68 vs 55 years, p < 0.001), with higher BMI (median 26.9 vs 24.7 kg/m2, p = 0.009), had a history of PVD or CAD (55% vs 30.2%, p = 0.003), had higher pulse pressure (median 60 vs 50, p = 0.017), MIS score (median 5 vs 4, p = 0.011), lower albumin (median 3.5 vs 3.8 g/dl, p = 0.011) and Mg levels (median 2.1 vs 2.4 mg/dl, p < 0.001). In univariate analysis age, CVD comorbidities, pulse pressure, CRP, BMI, albumin, Mg, MIS and use of b-blockers or calcium blockers were LVH predictors. In multivariate analysis, Mg was an independent predictor of LVH, adjusted for age, MIS and b-blockers. Considering LV geometry, lower Mg levels were mainly correlated with concentric LVH. CONCLUSION: Low serum magnesium levels seem to be an independent factor for LVH in hemodialysis and peritoneal dialysis patients.
PURPOSE: Left ventricular hypertrophy (LVH) represents one of the main risk factors for cardiovascular mortality in dialysis patients. Low serum magnesium Mg is related with increased mortality in general and dialysis population. Aim of our study was to evaluate the association of Mg with LVH and cardiac geometry in dialysis patients. METHODS: Hemodialysis (HD) and peritoneal dialysis (PD) patients from nine nephrology departments were included. Echocardiographic LVH was defined by LV mass index > 95 g/m2 in women and > 115 g/m2 in men. Four LV geometric patterns were defined: normal, concentric remodeling, eccentric LVH and concentric LVH. Demographic and laboratory data were collected. RESULTS: 133 patients (68 HD, 65 PD) with a median age of 63 years (IQR 52-74) were studied. Mg correlated positively with creatinine, HDL and negatively with CRP levels and BMI. There were no significant differences in Mg between the modality groups. 80 patients presented LVH (43 HD and 37 PD patients). Patients with LVH were older (median age 68 vs 55 years, p < 0.001), with higher BMI (median 26.9 vs 24.7 kg/m2, p = 0.009), had a history of PVD or CAD (55% vs 30.2%, p = 0.003), had higher pulse pressure (median 60 vs 50, p = 0.017), MIS score (median 5 vs 4, p = 0.011), lower albumin (median 3.5 vs 3.8 g/dl, p = 0.011) and Mg levels (median 2.1 vs 2.4 mg/dl, p < 0.001). In univariate analysis age, CVD comorbidities, pulse pressure, CRP, BMI, albumin, Mg, MIS and use of b-blockers or calcium blockers were LVH predictors. In multivariate analysis, Mg was an independent predictor of LVH, adjusted for age, MIS and b-blockers. Considering LV geometry, lower Mg levels were mainly correlated with concentric LVH. CONCLUSION: Low serum magnesium levels seem to be an independent factor for LVH in hemodialysis and peritoneal dialysis patients.
Authors: Wolfgang Lieb; Philimon Gona; Martin G Larson; Jayashri Aragam; Michael R Zile; Susan Cheng; Emelia J Benjamin; Ramachandran S Vasan Journal: JACC Cardiovasc Imaging Date: 2014-08-13
Authors: Rajiv Saran; Bruce Robinson; Kevin C Abbott; Jennifer Bragg-Gresham; Xiaoying Chen; Debbie Gipson; Haoyu Gu; Richard A Hirth; David Hutton; Yan Jin; Alissa Kapke; Vivian Kurtz; Yiting Li; Keith McCullough; Zubin Modi; Hal Morgenstern; Purna Mukhopadhyay; Jeffrey Pearson; Ronald Pisoni; Kaitlyn Repeck; Douglas E Schaubel; Ruth Shamraj; Diane Steffick; Megan Turf; Kenneth J Woodside; Jie Xiang; Maggie Yin; Xiaosong Zhang; Vahakn Shahinian Journal: Am J Kidney Dis Date: 2019-11-05 Impact factor: 8.860
Authors: Thorsten Reffelmann; Marcus Dörr; Till Ittermann; Christian Schwahn; Henry Völzke; Jörg Ruppert; Daniel Robinson; Stephan B Felix Journal: Atherosclerosis Date: 2010-09-22 Impact factor: 5.162
Authors: Ernesto Paoletti; Luca De Nicola; Francis B Gabbai; Paolo Chiodini; Maura Ravera; Laura Pieracci; Sonia Marre; Paolo Cassottana; Sergio Lucà; Simone Vettoretti; Silvio Borrelli; Giuseppe Conte; Roberto Minutolo Journal: Clin J Am Soc Nephrol Date: 2015-12-14 Impact factor: 8.237
Authors: Carmine Zoccali; Francesco A Benedetto; Francesca Mallamaci; Giovanni Tripepi; Giuseppe Giacone; Alessandro Cataliotti; Giuseppe Seminara; Benedetta Stancanelli; Lorenzo S Malatino Journal: J Am Soc Nephrol Date: 2004-04 Impact factor: 10.121